---
title: GRoningen Early-PD Ambroxol Treatment Pharmacokinetics
euct_id: 2024-519088-16-01
phase: Phase 3
status: Not yet recruiting
sponsor: Universitair Medisch Centrum Groningen
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-519088-16-01"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-519088-16-01"
ctis_last_updated: "2025-07-17T03:41:25.407070214"
source: EU Clinical Trials Information System (CTIS)
---
# GRoningen Early-PD Ambroxol Treatment Pharmacokinetics

**EU CT Number:** [2024-519088-16-01](https://euclinicaltrials.eu/ctis-public/view/2024-519088-16-01)

## Key Facts

- **Phase:** Phase 3
- **Status:** Not yet recruiting
- **Sponsor:** Universitair Medisch Centrum Groningen
- **Start Date:** 2025-06-02
- **Completion Date:** 2026-01-31
- **Conditions:** Parkinson's disease

## Member States

Trial is authorized in 1 member state: Netherlands.

## Sites (2)

- Universitair Medisch Centrum Groningen, Groningen, Netherlands
- CTC Netherlands B.V., Groningen, Netherlands

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-519088-16-01*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-519088-16-01*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-519088-16-01*